Viewing StudyNCT01103791



Ignite Creation Date: 2024-05-05 @ 10:26 PM
Last Modification Date: 2024-10-26 @ 10:18 AM
Study NCT ID: NCT01103791
Status: COMPLETED
Last Update Posted: 2017-05-05
First Post: 2010-04-05

Brief Title: A Trial to Determine the Maximum Tolerated Dose and Evaluate the Safety and Pharmacokinetics of Docetaxel-PNP Polymeric Nanoparticle Formulation of Docetaxel in Subjects With Advanced Solid Malignancies
Sponsor: Samyang Biopharmaceuticals Corporation
Organization: Samyang Biopharmaceuticals Corporation

Key Dates - Follows AllAPIJSON File Order

Start Date: 2010-04
Start Date Type: ACTUAL
Primary Completion Date: 2011-09
Primary Completion Date Type: ACTUAL
Completion Date: 2012-04
Completion Date Type: ACTUAL
First Submit Date: 2010-04-05
First Submit QC Date: April 14 2010
Study First Post Date: 2010-04-15
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-05-02
Last Update Post Date: 2017-05-05
Last Update Post Date Type: ACTUAL